Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2014
04/10/2014US20140099380 Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture
04/10/2014US20140099369 Tamper-resistant oral opioid agonist formulations
04/10/2014US20140099343 Ophthalmic Device, and Method of Use Thereof, for Increasing Ocular Boundary Lubrication
04/10/2014US20140099342 Botulinum nanoemulsions
04/10/2014US20140099331 Zwitterionic immunomodulators for the teatment of asthma and allergy
04/10/2014US20140099319 Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
04/10/2014US20140099314 S. aureus polypeptide and antibodies
04/10/2014US20140099307 New Dendritic Cell Co-Stimulatory Molecules
04/10/2014US20140099305 Compositions and methods for cancer immunotherapy
04/10/2014US20140099298 Botulinum toxin treatments of Depression
04/10/2014US20140099297 Ace2 polypeptide
04/10/2014US20140099296 Topically or orally applied aloe, distilled water, sodium chloride, and lysozyme mixture and method of producing the mixture
04/10/2014US20140099295 Methods of Treating Glucose Metabolism Disorders
04/10/2014US20140099283 2'-chloro nucleoside analogs for hcv infection
04/10/2014US20140099282 Modulating innate immune cell activity by lunasin and selected cytokines
04/10/2014US20140099279 Metal alloys for medical devices
04/10/2014US20140099254 Combination therapy for inducing immune response to disease
04/10/2014DE202013010690U1 Pharmazeutische und therapeutische Verwendungen von G-SH (reduziertes Glutathion), SAG (S-acetyl-Glutathion) auch im mikkronisierten Bereich von 1 bis 200 my und 1 bis 200 nm Pharmaceutical and therapeutic uses of G-SH (reduced glutathione), SAG (S-acetyl-glutathione) in mikkronisierten range of 1 to 200 microns and 1 to 200 nm
04/10/2014DE102012019882A1 Peptide zur Behandlung und Frühdiagnose von Morbus Alzheimer und anderer Tauopathien Peptides for the treatment and early diagnosis of Alzheimer's disease and other tauopathies
04/09/2014EP2716661A1 Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof
04/09/2014EP2716656A1 Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
04/09/2014EP2716652A1 Anti-fatty acid synthase polypeptide and use thereof
04/09/2014EP2716300A1 Application for prdx2 and/or prdx6 in preparation of pharmaceutical composition to treat or prevent damage, aging or disease resulting from increase of reactive oxygen species
04/09/2014EP2716299A2 Peptide bfp 4 for promoting bone formation or vasculogenesis, and application therefor
04/09/2014EP2716298A1 A nod2-dependant pathway of cytoprotection of stem cells
04/09/2014EP2716297A1 Activity enhancer for anticancer agent
04/09/2014EP2714909A1 Method of producing factor viii proteins by recombinant methods
04/09/2014EP2714888A2 Recombinant yeast
04/09/2014EP2714730A1 Novel antigen peptide and uses thereof
04/09/2014EP2714720A1 A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
04/09/2014EP2714719A2 Dispersion and detachment of cell aggregates
04/09/2014EP2714718A2 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
04/09/2014EP2714716A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
04/09/2014EP2714095A2 Non-peptidyl polymer-insulin multimer and method for producing the same
04/09/2014EP2714093A1 Therapeutic proteins with increased half-life and methods of preparing same
04/09/2014EP2714088A1 Mucosal delivery of drugs
04/09/2014EP2714070A1 Long-acting glp-1/glucagon receptor agonists
04/09/2014EP2714069A2 Long duration dual hormone conjugates
04/09/2014EP2714068A2 Extracellular matrix material conduits and methods of making and using same
04/09/2014EP2714067A1 Amylin peptides and derivatives and uses thereof
04/09/2014EP2714066A1 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
04/09/2014EP2714065A2 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
04/09/2014EP2714064A1 Blockade of inflammatory proteases with theta - defensins
04/09/2014EP2714063A1 Vegf-d/vegfr2/3-mediated regulation of dendrites
04/09/2014EP2714062A1 Nanogels
04/09/2014EP2714026A2 Modulation of the ubiquitin-proteasome system (ups)
04/09/2014EP2714004A1 Controlled release peptide formulations
04/09/2014EP2714001A2 New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide
04/09/2014CN103717615A Pcsk9-binding polypeptides and methods of use
04/09/2014CN103717232A Lixisenatide as add-on therapy to basal insulin in type 2 diabetes
04/09/2014CN103717231A Dry powder vancomycin compositions and associated methods
04/09/2014CN103717230A Product for the parenteral nutrition of obese intensive-care patients
04/09/2014CN103717226A Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
04/09/2014CN103717219A Left ventricular diastolic function improving agent
04/09/2014CN103717208A Formulations for wound therapy
04/09/2014CN103717205A Treatment of cancers and metastases with suspensions of cilengitide in carrier
04/09/2014CN103710414A Preparation method and application of mussel oligopeptide
04/09/2014CN103710311A Cell strain capable of stably secreting and expressing IL-24 recombinant protein, and construction and application thereof
04/09/2014CN103709242A Recombinant protein based on fugu rubripes FoxO1 gene as well as preparation method and application thereof
04/09/2014CN103709234A FVIII peptides and their use in tolerising haemophiliacs
04/09/2014CN103709232A Polypeptide capable of inhibiting human immunodeficiency virus infection activity, and related bacteriophage
04/09/2014CN103709231A Glucosamine modified RGD oligopeptides derivative, preparation method and application thereof
04/09/2014CN103705926A Pharmaceutical composition used for preventing primary tumor metastasis after exairesis
04/09/2014CN103705914A Staphylococcus aureus vaccine and preparation method thereof
04/09/2014CN103705913A Application of botulinum neurotoxin serotype A in preparing medicine for treating raynaud syndrome
04/09/2014CN103705912A Composite lysozyme oral spray and preparation method thereof
04/09/2014CN103705911A Methods for administering long-lasting hypoglycemic agents
04/09/2014CN103705910A Ziconotide injection hypodermic implant and preparation method thereof
04/09/2014CN103705909A Drug for painless induced abortion
04/09/2014CN103705908A Lyophilized pharmaceutical composition containing thymopentin and preparation method thereof
04/09/2014CN103705907A Preparation method and application of turtle shell active polypeptide extractive
04/09/2014CN103705494A Insulin nano transdermal patch and preparation method thereof
04/09/2014CN103704703A Yam and jujube dispersible tablets and preparation method thereof
04/09/2014CN103141892B Cucumber seed beverage and preparation method and application thereof
04/09/2014CN103041369B Application of phycocyanin in preparation of drug for preventing and treating male reproduction toxicity caused by organophosphorus pesticide
04/09/2014CN102942624B Galectin-3 binding protein, preparation and application thereof
04/09/2014CN102935224B Medicinal extract ointment for treating skin scald
04/09/2014CN102920738B Production method of active earthworm protein
04/09/2014CN102895650B Application of cyclotides ingredients in zizyphus jujube roots
04/09/2014CN102824332B Preparation method of antimicrobial peptide slow-release microcapsules
04/09/2014CN102807612B Polypeptide fragment and preparation method and application thereof
04/09/2014CN102643339B GLP-1 analogs, preparation method thereof application thereof
04/09/2014CN102617718B Bran coat antitumor active protein, as well as preparation method and applications thereof
04/09/2014CN102580056B Controlled-release injection containing antidiuresis components and preparation method thereof
04/09/2014CN102526333B Composition for regulating blood fat and protecting heart and blood vessels
04/09/2014CN102470166B Dipeptidyl peptidase-4 inhibitor
04/09/2014CN102470164B PTH-containing therapeutic/prophylactic agent for osteoporosis, characterized in that PTH is administered once week at unit dose of 100 to 200 units
04/09/2014CN102367277B Polymer conjugates of mutated neublastin
04/09/2014CN102206281B Fusion protein TETPH, expression vector and construction method thereof
04/09/2014CN102186493B Nutritional composition to promote healthy development and growth
04/09/2014CN102164610B Compositions for treatment of pain and/or inflamation
04/09/2014CN102076222B Composition comprising carbohydrates and peptides which comprise tryptophan
04/09/2014CN102008628B Medicament for treating female genital tract virus infection and preparation method of sustained-release preparation of medicament
04/09/2014CN101845079B Hexapeptide or derivative thereof and medical application thereof
04/09/2014CN101824082B N-end deletion type p43 protein and application thereof in medicaments for treating tumors
04/09/2014CN101511867B Cytokine derivatives
04/09/2014CA2829129A1 Infusion site leak detection device
04/08/2014US8691967 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
04/08/2014US8691951 Type I-type IV collagen hybrid gel
04/08/2014US8691949 Peptide having anti-diabetic activity and use thereof
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 3163